These foods do not need to be eliminated permanently, but reducing or avoiding them, especially during the dose escalation phase, will make your experience significantly more comfortable
Both semaglutide and tirzepatide are well known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes
We had to dig through multiple help articles before figuring out that the right path is to email [email protected]
Long-term continuous use data in humans is limited, so cycling is the more cautious approach
Successful weight loss may potentially reduce long-term cancer risk, though this benefit requires years to manifest and evidence specifically for pharmacotherapy-induced weight loss is still emerging
How much fiber should you take on GLP-1 medications